| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_2dc9a78dd4b3a699238d6c136eab8d02 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2310-33
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2310-321
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2310-318
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2310-17 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P11-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P11-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-117
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P29-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P17-00 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K48-00 |
| filingDate |
2005-11-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_073f9d808d98b02d8e5c762c89db3b1f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_de69d05f1bd46e003a37caf8d0533e7c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_aeeaecb9a85afbcb54c2e4fadf43b228 |
| publicationDate |
2008-10-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
MX-2008006004-A |
| titleOfInvention |
IMMUNOSTIMULATING PROPERTIES OF OLIGONUCLEOTID BASED COMPOUNDS THAT INCLUDE MODIFIED IMMUNOSTIMULATING DINUCLEOTIDES. |
| abstract |
The invention relates to the therapeutic use of oligonucleotides as immunostimulatory agents in immunotherapy applications; more particularly, the invention provides immunostimulatory oligonucleotides for use in methods to generate an immune response or to treat a patient in need of immunostimulation; the immunostimulatory oligonucleotides of the invention preferably comprise novel purines; The immunostimulatory oligonucleotides according to the invention also comprise at least two oligonucleotides linked at their 3 'ends, internucleotide bonds or functionalized nucleobase or sugar to a non-nucleotide linker, at least one of the oligonucleotides being an immunostimulatory oligonucleotide and has a 5 'end accessible. |
| priorityDate |
2005-11-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |